Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Dandoy

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Transplantation|February 20, 2016
The Noninvasive Urinary Polyomavirus Haufen Test Predicts BK Virus Nephropathy in Children After Hematopoietic Cell Transplantation: A Pilot StudyBenjamin L Laskin, Harsharan K Singh, Ulf H Beier, et al.
Haematologica|September 21, 2023
Dabrafenib and trametinib in Langerhans cell histiocytosis and other histiocytic disordersEily Cournoyer, Justin Ferrell, Susan Sharp, et al.
Transplantation and Cellular Therapy|January 15, 2025
Oxidative Stress Early After Hematopoietic Stem Cell TransplantEleanor Cook, Lucille Langenberg, Nathan Luebbering, et al.
Blood|May 31, 2014
Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adultsSonata Jodele, Stella M Davies, Adam Lane, et al.
Blood Reviews|April 22, 2023
How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy?Mark Juckett, Christopher Dandoy, Zachariah DeFilipp, et al.
Haematologica|February 19, 2026
Neutrophil extracellular traps, endothelial injury and use of abatacept for graft <i>versus</i> host disease prophylaxisAzada Ibrahimova, Nathan Luebbering, Lauren Strecker, et al.
The Lancet. Haematology|January 22, 2021
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort studyAkshay Sharma, Neel S Bhatt, Andrew St Martin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2014
Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sourcesKaren K Ballen, Steven Joffe, Ruta Brazauskas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2015
Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab RegimenRebecca A Marsh, Marepalli B Rao, Aharon Gefen, et al.
Haematologica|June 2, 2016
Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant ResearchAleksandr Lazaryan, Tao Wang, Stephen R Spellman, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Transplantation|February 20, 2016
The Noninvasive Urinary Polyomavirus Haufen Test Predicts BK Virus Nephropathy in Children After Hematopoietic Cell Transplantation: A Pilot StudyBenjamin L Laskin, Harsharan K Singh, Ulf H Beier, et al.
Haematologica|September 21, 2023
Dabrafenib and trametinib in Langerhans cell histiocytosis and other histiocytic disordersEily Cournoyer, Justin Ferrell, Susan Sharp, et al.
Transplantation and Cellular Therapy|January 15, 2025
Oxidative Stress Early After Hematopoietic Stem Cell TransplantEleanor Cook, Lucille Langenberg, Nathan Luebbering, et al.
Blood|May 31, 2014
Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adultsSonata Jodele, Stella M Davies, Adam Lane, et al.
Blood Reviews|April 22, 2023
How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy?Mark Juckett, Christopher Dandoy, Zachariah DeFilipp, et al.
Haematologica|February 19, 2026
Neutrophil extracellular traps, endothelial injury and use of abatacept for graft <i>versus</i> host disease prophylaxisAzada Ibrahimova, Nathan Luebbering, Lauren Strecker, et al.
The Lancet. Haematology|January 22, 2021
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort studyAkshay Sharma, Neel S Bhatt, Andrew St Martin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2014
Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sourcesKaren K Ballen, Steven Joffe, Ruta Brazauskas, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 14, 2015
Experience with Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Hematopoietic Cell Transplantation in Patients with Nonmalignant Diseases Reveals Good Outcomes and That the Risk of Mixed Chimerism Depends on Underlying Disease, Stem Cell Source, and Alemtuzumab RegimenRebecca A Marsh, Marepalli B Rao, Aharon Gefen, et al.
Haematologica|June 2, 2016
Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant ResearchAleksandr Lazaryan, Tao Wang, Stephen R Spellman, et al.
Pageof 5